49 results
8-K
SCTL
Societal CDMO Inc
23 Aug 23
Departure of Directors or Certain Officers
4:13pm
for the firm’s health care-focused investment strategy. Mr. Arens graduated from Purdue University with a bachelor of science degree. The Board … innovative life science companies with high growth potential. For the past 15 years, he solely has managed dedicated health care portfolios.
The Board has
8-K
EX-10.2
SCTL
Societal CDMO Inc
26 Nov 19
Entry into a Material Definitive Agreement
4:54pm
group health, life, dental, accidental death and dismemberment, health care reimbursements, dependent care assistance and disability benefits.
1.7 … , accidental death and dismemberment, health care reimbursements, dependent care assistance and disability benefits.
1.22. “Recro Option” means each option
8-K
EX-10.1
SCTL
Societal CDMO Inc
18 Apr 19
Entry into a Material Definitive Agreement
6:05am
to wholesalers and other distributors, buying groups, health care insurance carriers, pharmacy benefit management companies, health maintenance … organizations, other institutions or health care organizations or other customers;
(iv) reasonable estimates for amounts due to third parties on account
8-K
EX-99.1
5h7xrzvxbl
7 May 18
Other Events
9:41am
8-K
EX-99.1
gsh604sd
31 Oct 19
Other Events
10:10am
8-K
EX-99.1
fzknrib
1 Oct 18
Recro Announces Expansion of CDMO Service Capabilities
12:00am
8-K
EX-99.1
oxa8h3w60ft8zk wc
9 Oct 18
Recro Pharma Announces PDUFA Date for IV Meloxicam
6:07am
8-K
EX-99.1
1jjzghogk t0wbvmts
28 Mar 19
Recro Pharma Appoints Arnaud Ajdler to Its Board of Directors
6:05am
8-K
EX-99.1
oh1woo lafhdc
13 Nov 19
Other Events
7:16am
8-K
EX-99.1
k5a103n1k7 szd5fsv7g
30 Apr 18
Other Events
7:15am
10-K
qj4 u3gmcxlr4e
25 Mar 15
Annual report
12:00am
8-K
EX-99.1
1203657x8sj2j9ik68
5 Apr 19
Cost Associated with Exit or Disposal Activities
4:01pm
8-K
EX-99.1
7r3km o0o7n9xq01antv
10 Dec 18
Other Events
2:07pm
424B3
jz6qp ctx
26 Feb 15
Prospectus supplement
12:00am
424B4
te8w3
7 Mar 14
Prospectus supplement with pricing info
12:00am
SC TO-T
EX-99
2n1c9rwh
11 Mar 24
Third party tender offer statement
4:05pm
8-K
EX-99.1
xbmngsq8yze pl
9 May 18
Recro Pharma Reports First Quarter 2018 Financial Results
7:01am
8-K
EX-99.1
snx35xaskyf9cqsjg5n
7 Nov 18
Recro Pharma Reports Third Quarter 2018 Financial Results
7:06am